Understanding cardiovascular risk
Blood pressure, lipids and other clinical findings can inform cardiovascular risk assessment. A fitness article cannot determine which tests or medicines an individual needs. Monitoring does not make an experimental compound or performance-enhancing regimen safe.
Why I looked into it
I looked into cardiovascular health because I wanted to understand blood pressure, haematocrit and lipid changes before they became a problem. This is a reason for reading the research, not a recommendation to use a compound. Keith O’Beirne.
Blood pressure and the wider picture
Home blood pressure monitoring can help a clinician interpret readings over time. A single clinic reading may be temporarily raised by the stress of the appointment, sometimes called a white-coat effect. Readings taken in consistent conditions are more useful for comparison; a clinician can advise on a validated monitor and interpret the results.
LDL should be read alongside HDL, triglycerides and other cardiovascular risk factors, rather than treating one number as the whole picture. A high HDL result does not cancel an elevated LDL result. Baseline blood results can provide a comparison before treatment decisions, with the choice of tests and any response agreed with a clinician.
MyBloods.ie is one I've used. A private result still needs clinical interpretation; it is not permission to start an experimental compound.
What telmisartan is authorised for
Telmisartan is an angiotensin II receptor blocker used in prescription medicines. The EMA product information for Micardis describes hypertension and defined cardiovascular-prevention indications. Those authorisations do not establish a role as protection against the risks of experimental compounds or performance-enhancing regimens.
Mechanistic interest in a medicine is a different question from a clinical benefit in a particular person. Blood pressure results and treatment options need to be interpreted by a clinician in the context of medical history.
Summary
Monitoring is a way to identify and assess risk, not a guarantee of protection. No blood-pressure medicine cancels the risks of other compounds. A GP can assess symptoms, measurements and treatment questions.